Immunic biopharmaceutical appoints Inderpal Singh as general counsel
Immunic, a clinical-stage biopharmaceutical company, announced the appointment of Inderpal Singh (pictured) as general counsel. In the role, Singh will be responsible for legal and compliance matters and will become part of the management team of Immunic.
Inderpal Singh joins Immunic with more than 20 years of Corporate and Commercial law experience. His most recent appointment was at Sandoz International, where he served as the Global Legal Head of Biopharma since January 2018. Before that, Singh served at Healthcare Business of Merck as Head of legal as well as Head of Global Manufacturing and Supply and Regional Counsel Middle East and Africa, Commonwealth of Independent States and Turkey. He also worked at Biogen Idec International (Europe) as Legal Director. Earlier in his career, Singh spent more than a decade at Pfizer, initially as a Director Legal, followed by Assistant General Counsel.
Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases.